Nacuda, Glory Belle D.
HRN: 05-41-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2022
CEFUROXIME 500MG (TAB)
10/10/2022
10/16/2022
PO
1 Tab
Q12H
S/p LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes